Skip to main content
Erschienen in: World Journal of Urology 5/2017

30.08.2016 | Original Article

Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis

verfasst von: Giuseppe Simone, Gabriele Tuderti, Umberto Anceschi, Rocco Papalia, Mariaconsiglia Ferriero, Leonardo Misuraca, Francesco Minisola, Riccardo Mastroianni, Manuela Costantini, Salvatore Guaglianone, Steno Sentinelli, Michele Gallucci

Erschienen in: World Journal of Urology | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To compare the oncologic outcomes of partial nephrectomy (PN) and radical nephrectomy (RN) for cT1-2/N0 renal tumors and pathologically confirmed pT1-pT3a-pNx clear cell (cc)-renal cell carcinoma (RCC). Few studies compared the oncologic outcomes of PN and RN for renal tumors >7 cm.

Methods

A prospective “renal cancer” database was queried for cT<3-cN0-cM0 and pT1a-pT3a-pNx cc-RCC. Out of 1650 cases treated between 2001 and 2013, 921 were cc-RCC and 666 met inclusion criteria, 232 of which treated with minimally invasive RN and 434 with MIPN. A 1:1 propensity score-matched (PSM) analysis was employed to minimize the selection bias of non-random assignment of patients to PN as opposed to RN. Kaplan–Meier method was used to compare the oncologic outcomes of the PSM cohorts. Survival rates were computed at 2, 5, and 10 years after surgery, and the log-rank test was applied to assess statistical significance between the two PSM groups.

Results

RN tumors were significantly larger (p < 0.001), with higher pT stages (p < 0.001), higher Fuhrman grades (p = 0.002) and a more frequent sarcomatoid differentiation (p = 0.04). After applying the PSM analysis, the two cohorts of 155 RN and 155 PN cases did not differ for all clinical and pathologic covariates (all p ≥ 0.32). PN and RN cohorts displayed comparable 5-year metastasis-free survival (88.9 vs 89.9 %, p = 0.811), local recurrence-free survival (94.2 vs 95.9 %, p = 0.283), overall survival (94.5 vs 96.8 %, p = 0.419) and cancer-specific survival (96 vs 98.6 %, p = 0.907) rates.

Conclusions

PN and RN for patients with cc-RCC larger than 7 cm provided equivalent oncologic outcomes. Safety and reproducibility of our findings should be further investigated in larger multicentric cohorts.
Literatur
1.
2.
Zurück zum Zitat Cho E, Adami H, Lindblad P (2011) Epidemiology of renal cell cancer. Hematol Oncol Clin N Am 25:651–665CrossRef Cho E, Adami H, Lindblad P (2011) Epidemiology of renal cell cancer. Hematol Oncol Clin N Am 25:651–665CrossRef
3.
Zurück zum Zitat Van Poppel H, Da Pozzo L, Albrecht W et al (2011) A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 59:543–552CrossRefPubMed Van Poppel H, Da Pozzo L, Albrecht W et al (2011) A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 59:543–552CrossRefPubMed
4.
Zurück zum Zitat Scosyrev E, Messing EM, Sylvester R et al (2014) Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. Eur Urol 65:372–377CrossRefPubMed Scosyrev E, Messing EM, Sylvester R et al (2014) Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. Eur Urol 65:372–377CrossRefPubMed
5.
Zurück zum Zitat Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130:461–470CrossRefPubMed Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130:461–470CrossRefPubMed
6.
Zurück zum Zitat Weight CJ, Larson BT, Fergany AF et al (2010) Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J Urol 1183:1317–1323CrossRef Weight CJ, Larson BT, Fergany AF et al (2010) Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J Urol 1183:1317–1323CrossRef
7.
Zurück zum Zitat Huang WC, Elkin EB, Levey AS, Jang TL, Russo P (2009) Partial nephrectomy versus radical nephrectomy in patients with small renal tumors—is there a difference in mortality and cardiovascular outcomes? J Urol 181:55–62CrossRefPubMed Huang WC, Elkin EB, Levey AS, Jang TL, Russo P (2009) Partial nephrectomy versus radical nephrectomy in patients with small renal tumors—is there a difference in mortality and cardiovascular outcomes? J Urol 181:55–62CrossRefPubMed
8.
Zurück zum Zitat Ljungberg B, Bensala K, Canfield S et al (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67:913–924CrossRefPubMed Ljungberg B, Bensala K, Canfield S et al (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67:913–924CrossRefPubMed
9.
Zurück zum Zitat Campbell SC, Novick AC, Belldegrun A et al (2009) Guideline for management of the clinical T1 renal mass. J Urol 182:1271–1279CrossRefPubMed Campbell SC, Novick AC, Belldegrun A et al (2009) Guideline for management of the clinical T1 renal mass. J Urol 182:1271–1279CrossRefPubMed
10.
Zurück zum Zitat Antonelli A, Ficarra V, Bertini R et al (2011) Elective partial nephrectomy is equivalent to radical nephrectomy in patients with clinical T1 renal cell carcinoma: results of a retrospective, comparative, multi-institutional study. BJU Int 109:1013–1018CrossRefPubMed Antonelli A, Ficarra V, Bertini R et al (2011) Elective partial nephrectomy is equivalent to radical nephrectomy in patients with clinical T1 renal cell carcinoma: results of a retrospective, comparative, multi-institutional study. BJU Int 109:1013–1018CrossRefPubMed
11.
Zurück zum Zitat Antonelli A, Cozzoli A, Nicolai M et al (2008) Nephron sparing surgery versus Radical nephrectomy in the treatment of intracapsular renal cell carcinoma up to 7 cm. Eur Urol 53:803–809CrossRefPubMed Antonelli A, Cozzoli A, Nicolai M et al (2008) Nephron sparing surgery versus Radical nephrectomy in the treatment of intracapsular renal cell carcinoma up to 7 cm. Eur Urol 53:803–809CrossRefPubMed
12.
Zurück zum Zitat Hansen J, Sun M, Bianchi M et al (2012) Assessment of cancer control outcomes in patients with high-risk renal cell carcinoma treated with partial nephrectomy. Urology 80:347–353CrossRefPubMed Hansen J, Sun M, Bianchi M et al (2012) Assessment of cancer control outcomes in patients with high-risk renal cell carcinoma treated with partial nephrectomy. Urology 80:347–353CrossRefPubMed
13.
Zurück zum Zitat Breau RH, Crispen PL, Jimenez RE et al (2010) Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy. J Urol 183:903–908CrossRefPubMed Breau RH, Crispen PL, Jimenez RE et al (2010) Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy. J Urol 183:903–908CrossRefPubMed
14.
Zurück zum Zitat Jeldres C, Patard JJ, Capitanio U et al (2009) Partial versus radical nephrectomy in patients with adverse clinical or pathologic characteristics. Urology 73:1300–1305CrossRefPubMed Jeldres C, Patard JJ, Capitanio U et al (2009) Partial versus radical nephrectomy in patients with adverse clinical or pathologic characteristics. Urology 73:1300–1305CrossRefPubMed
15.
Zurück zum Zitat Ramaswamy K, Kheterpal E, Pham H et al (2015) Significance of pathologic T3a upstaging in clinical T1 renal mass undergoing nephrectomy. Clin Genitourin Cancer 13:344–349CrossRefPubMed Ramaswamy K, Kheterpal E, Pham H et al (2015) Significance of pathologic T3a upstaging in clinical T1 renal mass undergoing nephrectomy. Clin Genitourin Cancer 13:344–349CrossRefPubMed
16.
Zurück zum Zitat Brierley JD, Gospodariwicz MK, Wittekind C (2009) TNM classification of malignant tumors. UICC International Union Against Cancer, 7th edn. Wiley-Blackwell, New York Brierley JD, Gospodariwicz MK, Wittekind C (2009) TNM classification of malignant tumors. UICC International Union Against Cancer, 7th edn. Wiley-Blackwell, New York
17.
18.
Zurück zum Zitat Poon SA, Silberstein JL, Chen LY et al (2013) Trends in partial and radical nephrectomy: an analysis of case logs from certifying urologists. J Urol 190:464–469CrossRefPubMedPubMedCentral Poon SA, Silberstein JL, Chen LY et al (2013) Trends in partial and radical nephrectomy: an analysis of case logs from certifying urologists. J Urol 190:464–469CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Roos FC, Brenner W, Muller M et al (2011) Oncologic long-term outcome of elective nephron-sparing surgery versus radical nephrectomy in patients with renal cell carcinoma stage pT1b or greater in a matched-pair cohort. Urology 77:803–808CrossRefPubMed Roos FC, Brenner W, Muller M et al (2011) Oncologic long-term outcome of elective nephron-sparing surgery versus radical nephrectomy in patients with renal cell carcinoma stage pT1b or greater in a matched-pair cohort. Urology 77:803–808CrossRefPubMed
20.
Zurück zum Zitat Papalia R, Simone G, Ferriero M et al (2012) Laparoscopic and robotic partial nephrectomy without renal ischaemia for tumours larger than 4 cm: perioperative and functional outcomes. World J Urol 30:671–676CrossRefPubMed Papalia R, Simone G, Ferriero M et al (2012) Laparoscopic and robotic partial nephrectomy without renal ischaemia for tumours larger than 4 cm: perioperative and functional outcomes. World J Urol 30:671–676CrossRefPubMed
21.
Zurück zum Zitat Lane BR, Golan S, Eggener S et al (2013) Differential use of partial nephrectomy for intermediate and high complexity tumors may explain variability in reported utilization rates. J Urol 189:2047–2053CrossRefPubMed Lane BR, Golan S, Eggener S et al (2013) Differential use of partial nephrectomy for intermediate and high complexity tumors may explain variability in reported utilization rates. J Urol 189:2047–2053CrossRefPubMed
22.
Zurück zum Zitat Ficarra V, Novara G, Secco S et al (2009) Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol 56:786–793CrossRefPubMed Ficarra V, Novara G, Secco S et al (2009) Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol 56:786–793CrossRefPubMed
Metadaten
Titel
Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis
verfasst von
Giuseppe Simone
Gabriele Tuderti
Umberto Anceschi
Rocco Papalia
Mariaconsiglia Ferriero
Leonardo Misuraca
Francesco Minisola
Riccardo Mastroianni
Manuela Costantini
Salvatore Guaglianone
Steno Sentinelli
Michele Gallucci
Publikationsdatum
30.08.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 5/2017
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-016-1923-2

Weitere Artikel der Ausgabe 5/2017

World Journal of Urology 5/2017 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.